Evaluation of Plasma Concentrations of Intravenous Lidocaine and Epidural Ropivacaine When Used in Combination in Major Abdominal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

January 28, 2024

Study Completion Date

October 2, 2024

Conditions
Abdominal Surgery by LaparotomyThoracic Epidural AnalgesiaAnalgesiaLidocaine Adverse Reaction
Interventions
OTHER

Blood sample

Lidocaine blood sample 30 min before the end of the surgery Lidocaine blood sample at the end of the infusion lidocaine and ropivacaine blood sample 2 h after the ropivacaine infusion of the TEA Ropivacaine blood sample 24h after the infusion of the TEA

DRUG

Lidocain

Lidocaine will be injected during the anaesthetic induction and infused until the surgical closure (30 minutes before the end) The occurrence of adverse events will be monitor by a physical examination and blood samples of lidocainemia and ropivacainemia in the perioperative period.

DRUG

ropivacaine

Lidocaine will be injected during the anaesthetic induction and infused until the surgical closure (30 minutes before the end), then ropivacaine will be injected in the TEA at the same time and infused during 24h. The occurrence of adverse events will be monitor by a physical examination and blood samples of lidocainemia and ropivacainemia in the perioperative period.

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER